VNDA
Vanda Pharmaceuticals Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | ||||||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing | ||||||||||||||
| Capital Expenditures | 998,000 | 490,000 | 383,000 | 679,000 | 552,000 | 1.8M | 1.0M | 368,000 | 1.7M | 176,000 | 2.0M | 275,000 | — | — |
| Acquisitions | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing | ||||||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Summary | ||||||||||||||
| Free Cash Flow | -110.4M | -16.2M | 12.4M | 31.3M | 63.7M | 50.0M | 44.9M | 29.6M | -3.6M | -39.8M | -46.9M | -28.7M | — | — |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — |